Changes in homocysteine and 8-iso-PGF2a levels in football and hockey players after a match

Research in Sports Medicine

Volumn 19, Issue 2, 2011, Pages 118-128

  Papapanagiotou, A ^a   Gissis, I ^b   Papadopoulos, C ^b   Souglis, A ^c   Bogdanis, G C ^c   Giosos, I ^c   Sotiropoulos, A ^c  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^c UNIVERSITY OF ATHENS   (Greece)

Author keywords

Football; Hockey; Homocysteine; Isoprostanes

Indexed keywords

8 EPI PROSTAGLANDIN F2ALPHA; 8-EPI-PROSTAGLANDIN F2ALPHA; DRUG DERIVATIVE; HOMOCYSTEINE; PROSTAGLANDIN F2 ALPHA;

ADOLESCENT; ADULT; ARTICLE; ATHEROSCLEROSIS; ATHLETE; BLOOD; HUMAN; PHYSIOLOGY; SPORT;

ADOLESCENT; ADULT; ATHEROSCLEROSIS; ATHLETES; DINOPROST; HOCKEY; HOMOCYSTEINE; HUMANS; SOCCER; YOUNG ADULT;

EID: 79959851782     PISSN: 15438627     EISSN: 15438635     Source Type: Journal    
DOI: 10.1080/15438627.2011.556532     Document Type: Article

References (45)

1. Boreham, C. A., Kennedy, R. A., Murphy, M. H., Tully, M., Wallace, W. F., & Young, I. (2005). Training effects of short boys of stair climbing on cardioresporatory fitness blood lipids and homocysteine in sedentary young women. British Journal of Sports Medicine, 39, 590-593. (Pubitemid 41265302)
2. Boushey, C., Beresford, S., Omenn, G., & Motulsky, A. (1995). A quantitative assessment of plasma homocysteine as a risk factor for vascular disease: probable benefits of increasing folic acid intakes. Journal of the American Medical Association, 274, 1049-1057.
3. Brattström, L., Lindgren, A., & Israelsson, B. (1992). Hyperhomocysteinaemia in stroke, prevalence, cause, and relationships to type of stroke and stroke risk factors. European Journal of Clinical Investigation, 22, 214-221.
4. Cattaneo, M. (1999). Hyperhomocysteinemia, atherosclerosis and thrombosis. Journal of Thrombosis and Haemostasis, 81, 165-176. (Pubitemid 29078298)
5. De Bree, A., Verschuren, W. M., Blom, H. J., & Kromhout, D. (2001). Lifestyle factors and plasma homocyeine concentrations in a general population sample. American Journal of Epidemiology, 15; 154, 150-154.
6. De Cree, C., Malinow, M. R., Van Kranenburg, G. P., Geurten, P. G., Longford, N. T., & Keizer, H. A. (1999). Influence of exercise and menstrual cycle phase on plasma homocysteine levels in young women-a prospective study. Scandinavian Journal of Medicine & Science in Sports, 9, 272-278.
7. Di Minno, G., Davi, G., & Margaglione, M. (1993). Abnormally high thromboxane biosynthesis in homozygous homocysteinuria. Evidence for platelets involvement and probucol-sensitive mechanism. Journal of Clinical Investigation, 92, 1400-1406. (Pubitemid 23273917)
8. Dudman, N., Hicks, C., Lynch, J., Wicken, D., & Wang, J. (1991). Homocysteine thiolactone disposal by human arterial endothelial cells and serum in vitro. Journal of Atherosclerosis and Thrombosis, 11, 663-670.
9. Durnin, J. & Womersley, J. (1974). Body fat assessed from total body density and its estimation from skinfold thickness: measurements on 481 men and women aged 16 to 72 years. British Journal of Nutrition, 32, 77-97.
10. Elesber, A., Best, P., Lennon, R., Mathes, V., Rihal, C., Lerman, L., & Lerman, A. (2006). Plasma 8-iso-prostaglandin F2alpha, a marker of oxidative stress, is increased in patients with acute myocardial infarction. Free Radical Research, 40, 385-391. (Pubitemid 43336043)
11. Grubben, M. J., Boers, G. H., Blom, H. J., Broekhuizen, R., de Jong, R., van Rijt, L., de Ruijter, E., Swinkels, D. W., Nagengast, F. M., & Katan, M. B. (2000). Unfiltered coffee increases plasma homocysteine concentrations in healthy volunteers: A randomized trial. American Journal of Clinical Nutrition, 71, 480-484. (Pubitemid 30061226)
12. Hajjar, K. A. (1993). Homocysteine-induced modulation of tissue plasminogen activator binding to its endothelial cell membrane receptor. Journal of Clinical Investigation, 91, 2873-2979.
13. Hajjar, K., Mauri, L., Jacovina, A., Zhong, F., Mirza, U., Padovan, J., & Chait, B. (1998). Tissue plasminogen activator binding to annexin II tail domain. Direct modulation by homocysteine. Journal of Biological Chemistry, 273, 9987-9993. (Pubitemid 28183100)
14. Harker, L., Ross, R., Slichter, S., & Scott, C. (1976). Homocysteine-induced arteriosclerosis: The role of endothelial cell injury and platelet response in its genesis. Journal of Clinical Investigation, 58, 731-741.
15. Hayashi, T., Honda, G., & Suzuki, K. (1992). An atherogenic stimulus homocysteine inhibits cofactor activity of thrombomodulin and enhances thrombomodulin expression in human umbilical vein endothelial cells. Blood, 79, 2930-2936.
16. Hermann, M., Schorr, H., Obeid, R., Scharhag, J., Urhausen, A., Kindermann, W., & Herrmann, W. (2003a). Homocysteine increases during endurance exercise. Clinical Chemistry and Laboratory Medicine, 41, 1518-1524. (Pubitemid 37493570)
17. Herrmann, M., Wilkinson, J., Schorr, H., Obeid, R., Georg, T., Urhausen, A., Scharhag, J., Kindermann, W., & Herrmann, W. (2003b). Comparison of the influence of volume-oriented training and high-intensity interval training on serum homocysteine and its cofactors in young, healthy swimmers. Clinical Chemistry and Laboratory Medicine, 41, 1525-1531. (Pubitemid 37493571)
18. Kang, S., Wong, P., Cook, H., Norusis, M., & Messer, J. (1986). Protein-bound homocysteine. A possible risk factor for coronary artery disease. Journal of Clinical Investigation, 77, 1482-1486. (Pubitemid 16047091)
19. Lentz, S. & Sadler, J. (1991). Inhibition of thrombomodulin surface expression and protein C activation by the thrombogenic agent homocysteine. Journal of Clinical Investigation, 88, 1906-1914.
20. Longmire, A., Swift, L., Roberts, L., Awad, J., Burk, R., & Morrow, J. (1994). Effect of oxygen tension on the generation of F2 isoprostanes and malondialdehyde in peroxidizing rat liver microsomes. Biochemical Pharmacology, 47, 1173-1177. (Pubitemid 24127931)
21. Majors, A., Ehrhart, L., & Pezacka, E. (1997). Homocysteine as a risk factor for vascular disease. Enhanced collagen production and accumulation by smooth muscle cells. Arteriosclerosis, Thrombosis, and Vascular Biology, 17, 2074-2081. (Pubitemid 28057110)
22. Mayer, E., Jacobsen, D., & Robinson, K. (1996). Homocysteine and coronary Atherosclerosis. Journal of the American College of Cardiology, 27, 517-527. (Pubitemid 26081913)
23. McDonald, L., Bray, C., Field, C., Love, F., & Davies, B. (1964). Homocystinuria, thrombosis and the blood-platelets. Lancet, 1, 745-746.
24. Morrow, J., Awad, J., Kato, T., Takahashi, K., Badr, K., Roberts, L., & Rurk, B. (1992). Formation of novel non-cyclooxygenase-derived prostanoids (F2-isoprostanes) in carbon-tetrachloride hepatotoxicity. An animal model of lipid peroxidation. Journal of Clinical Investigation, 90, 2502-2507. (Pubitemid 23010071)
25. Morrow, J., Hill, K., Burk, R., Nammour, T., Bard, K., & Roberts, L. (1990). A series of prostaglandin F2-like compounds are produced in vivo in human by a noncyclooxygenase, free radical-catalyzed mechanism. Proceedings of the National Academy of Sciences, 87, 9383-9387. (Pubitemid 120030630)
26. Nieman, D., Henson, D, McAnulty, S., McAnulty, L., Swick, N., Utter, A., Vinci, D., Opiela, S., & Morrow, J. (2002). Influence of vitamin C supplementation on oxidative and immune changes after an ultramatathon. Journal of Applied Physiology, 92, 1970-1977. (Pubitemid 34666424)
27. O'Connor, D., Mihelich, E., & Coleman, M. (1984). Stereo chemical course of the autoxidative of lipid hydroperoxides to prostaglandin-like bicycle endoperoxides. Journal of the American Chemical Society, 106, 3577-3584. (Pubitemid 14609840)
28. Pratico, D., Smyth E. M., Violi, F., & Fitzgerald, G. (1996). Local amplification of platelet function by 8-epi PGF2a is not mediated by thromboxane receptor isoforms. Journal of Biological Chemistry, 271, 14916-14924.
29. Refsum, H. & Uelamd, P. (1998). Homocysteine and cardiovascular disease. Annual Review of Medicine, 49, 31-62. (Pubitemid 28197439)
30. Reilly, T. & Borrie, A. (1992). Physiology applied to field hockey. Sports Medicine, 14, 10-28.
31. Reilly, T. & Seaton, A. (1990). Physiological strain unique to field hockey. Journal of Sports Medicine and Physical Fitness, 30, 142-146.
32. Rinder, M. R., Spina, R. J., & Ehsani, A. A. (2000). Enhanced endothelium dependent vasodilation in older endurance-trained men. Journal of Applied Physiology, 88, 761-766. (Pubitemid 30097124)
33. Rodgers, G. & Conn, M. (1990). Homocysteine, an atherogenic stimulus reduces protein C activation by arterial and venous endothelial cells. Blood, 75, 895-901. (Pubitemid 20067188)
34. Rodgers, G. & Kane, W. (1986). Activation of endogenous factor V by homocysteineinduced vascular endothelial cell activator. Journal of Clinical Investigation, 77, 1909-1916. (Pubitemid 16062647)
35. Rokach, J., Khanapure, S., Hwang, S., Adiyaman, M., Lawson, J., & Fitzgerald, G. (1997). The isoprostanes: A prospective. Prostaglandins, 54, 823-851.
36. Ruiz, J. R., Hurting-Wennlof, A., Ortega, F. B., Patterson, E., Nilsson, T. K., Castillo, M. J., & Sjöström, M. (2007). Homocysteine levels in children and adolescents are associated with the methlenetetrahydrofolate reductase 677C>T genotype, but not with physical activity, fitness or fatness: The European Youth Heart study. British Journal of Nutrition, 97, 255-262. (Pubitemid 46671798)
37. Stabler, S., Marcell, P., Podell, E., Allen, R., Savage, D., & Lindenbaum, J. (1988). Elevation of total homocysteine in the serum of patients with cobalamin or folate deficiency detected by capillary gas chromatography-mass spectrometry. Journal of Clinical Investigation, 81, 466-474. (Pubitemid 18075242)
38. Stamler, J., Osdorne, J., Jaraki, O., Rabbani, L., Mullins, M., Singel, D., & Loscalzo, J. (1993). Adverse vascular effects of homocysteine are modulated by endothelium-derived relaxing factor and related oxides of nitrogen. Journal of Clinical Investigation, 91, 308-318. (Pubitemid 23037286)
39. Starkebaum, G. & Harlan, J. (1986). Endothelial cell injury due to copper - catalyzed hydrogen peroxide generation from homocysteine. Journal of Clinical Investigation, 77, 1370-1376. (Pubitemid 16047161)
40. Steensberg, A., Morrow, J, Toft, A. D., Bruunsgaard, H., & Pedersen, B. (2002). Prolonged exercise, lymphocyte apoptosis and F2-isoprostanes. European Journal of Applied Physiology, 87, 38-42. (Pubitemid 41399029)
41. Takahashi, K., Nammour, T., Fukunaga, M., Ebert, J., Morrow, J., Roberts, L., Hoover, R., & Badr, K. (1992). Glomerular actions of a free radical-generated novel prosta-glandin, 8-epiPGF2a, in rar. Evidence for interaction with thromboxane A2 receptors. Journal of Cliinical Investigation, 90, 136-141.
42. Ueland P., Refsum H., & Brattström L. (1992). Plasma homocysteine and cardiovascular disease. Atherosclerotic Cardiovascular Disease, Haemostasis and Endothelial Function (pp. 183-236). New York, NY: Marcel Dekker.
43. Van den Brandhof, W., Haks, K., Schouten, E., & Verhoef, P. (2001). The relation between plasma cysteine, plasma homocysteine and coronary atherosclerosis. Atherosclerosis, 157, 403-409. (Pubitemid 32710019)
44. Verhoef, P., Stampfer, M. J., Buring, J. E., Gaziano, J. M., Allen, R. H., Stabler, S. P., Reynolds, R. D., Kok, F. J., Hennekens, C. H., & Willett, W. C. (1996). Homocysteine metabolism and risk of myocardial infarction: Relation with vitamins B6, B12, and folate. American Journal Epidemiology, 143, 845-859.
45. Wang, J., Dudman, N., & Wilcken, D. (1993). Effects of homocysteine and related compounds on prostacyclin production by cultured human vascular endothelial cells. Journal of Thrombosis and Haemostasis, 70, 1047-1052. (Pubitemid 24008823)